IDBE

ID Biomedical (IDBE)

ID Biomedical - Common Shares (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IDBE

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2005/12/09	00 : 00	PR Newswire (US)	ID Biomedical announces closing of acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/12/07	10 : 40	PR Newswire (US)	ID Biomedical announces receipt of court approval for acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/12/05	23 : 15	PR Newswire (US)	ID Biomedical provides update on application for court approval of acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/11/19	07 : 06	PR Newswire (US)	ID Biomedical announces rescheduling of court hearing to approve acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/11/17	07 : 28	PR Newswire (US)	ID Biomedical announces results of securityholders' votes relating to acquisition by GlaxoSmithKline	NASDAQ:IDBE
2005/11/11	00 : 28	PR Newswire (US)	ID Biomedical reports 2005 third quarter results	NASDAQ:IDBE
2005/10/24	23 : 40	PR Newswire (US)	ID Biomedical Provides Update on Vaccine Development Programs	NASDAQ:IDBE
2005/10/21	08 : 54	PR Newswire (US)	ID Biomedical announces mailing of meeting materials	NASDAQ:IDBE
2005/09/08	01 : 06	PR Newswire (US)	GlaxoSmithKline To Acquire ID Biomedical Corporation	NASDAQ:IDBE
2005/09/08	00 : 31	PR Newswire (US)	GlaxoSmithKline To Acquire ID Biomedical Corporation	NASDAQ:IDBE	ID Biomedical - Common Shares (MM)
2005/08/16	06 : 00	PR Newswire (US)	ID Biomedical reports 2005 second quarter results	NASDAQ:IDBE
2005/08/11	04 : 10	PR Newswire (US)	ID Biomedical announces 2005 second quarter release date and conference call	NASDAQ:IDBE
2005/07/12	23 : 00	PR Newswire (US)	ID Biomedical's flu vaccine granted Fast Track status by FDA	NASDAQ:IDBE
2005/05/26	23 : 30	PR Newswire (US)	ID Biomedical announces webcast of 2005 Annual General Meeting of Shareholders	NASDAQ:IDBE
2005/05/21	00 : 57	PR Newswire (US)	ID Biomedical announces webcast of 2005 Annual General Meeting of Shareholders	NASDAQ:IDBE
2005/05/17	06 : 00	PR Newswire (US)	ID Biomedical reports 2005 first quarter results	NASDAQ:IDBE
2005/05/11	23 : 30	PR Newswire (US)	ID Biomedical announces 2005 first quarter release date and conference call	NASDAQ:IDBE
2005/03/31	00 : 42	PR Newswire (US)	ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral Clinical Trial in the U.S.	NASDAQ:IDBE
2005/03/23	00 : 04	PR Newswire (US)	ID Biomedical receives positive data from clinical testing of its Group-Common Pneumococcal Vaccine	NASDAQ:IDBE
2005/03/17	06 : 01	PR Newswire (US)	ID Biomedical reports fiscal 2004 year end results	NASDAQ:IDBE
2005/03/15	23 : 30	PR Newswire (US)	ID Biomedical to pursue U.S. accelerated approval process for its influenza vaccine	NASDAQ:IDBE
2005/03/15	00 : 40	PR Newswire (US)	ID Biomedical announces 2004 year end earnings release date and conference call	NASDAQ:IDBE
2005/03/04	23 : 30	PR Newswire (US)	ID Biomedical closes sale and leaseback transactions	NASDAQ:IDBE
2005/01/26	23 : 15	PR Newswire (US)	ID Biomedical Announces Immunogenicity Results from Phase II Trial of Streptavax	NASDAQ:IDBE
2005/01/19	23 : 15	PR Newswire (US)	ID Biomedical begins development of pandemic influenza vaccine	NASDAQ:IDBE
2005/01/14	01 : 34	PR Newswire (US)	ID Biomedical announces final results from field efficacy trial of its intranasal flu vaccine	NASDAQ:IDBE
2005/01/11	01 : 16	PR Newswire (US)	ID Biomedical announces the beginning of a U.S. phase I clinical trial for plague vaccine candidate	NASDAQ:IDBE
2005/01/10	23 : 15	PR Newswire (US)	ID Biomedical Closes Financing Transaction	NASDAQ:IDBE
2005/01/10	23 : 01	PR Newswire (US)	CSC's DVC Enters Clinical Trial for Plague Vaccine Candidate	NASDAQ:IDBE	ID Biomedical - Common Shares (MM)
2005/01/07	23 : 15	PR Newswire (US)	ID Biomedical receives clearance for Fluviral clinical testing in the U.S.	NASDAQ:IDBE